Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease

Introduction: Corona Virus disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. The aim of this study was to investigate the impact of being on an Angiotensin-Converting Enzyme Inhibitors (ACEI) and/or Angiotensin Receptor B...

Descripción completa

Detalles Bibliográficos
Autores principales: ElAbd, Rawan, AlTarrah, Dana, AlYouha, Sarah, Bastaki, Hamad, Almazeedi, Sulaiman, Al-Haddad, Mohannad, Jamal, Mohammad, AlSabah, Salman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969499/
https://www.ncbi.nlm.nih.gov/pubmed/33748156
http://dx.doi.org/10.3389/fmed.2021.600385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969499/
https://www.ncbi.nlm.nih.gov/pubmed/33748156
http://dx.doi.org/10.3389/fmed.2021.600385

Ejemplares similares